Urology · Bel Air, MD
NPI
1861404022
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2 North Ave Ste 102
Bel Air, MD, 21014
Phone (443) 643-9900
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.9M
40,222 services
Medicare patients, 2024
811
Average age 76
Drug cost, 2024
$3.4M
3,114 prescriptions
Company payments, 2025
$2,127
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert F Hoofnagle Jr. was code 87798 (infectious agent detection by dna/rna), 18,772 times for 769 patients. In total Robert F Hoofnagle Jr. billed 40,222 services in 66 codes, and Medicare paid $1.9M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-25.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 87798 Infectious Agent Detection by DNA/RNA | Office | 18,772 | 769 | $34.31 | $644K |
| 87481 Infectious Agent Detection by DNA/RNA | Office | 7,220 | 769 | $34.31 | $248K |
| 87801 Infectious Agent Detection by DNA/RNA | Office | 4,338 | 769 | $68.63 | $298K |
| 87500 Infectious Agent Detection by DNA/RNA | Office | 1,445 | 768 | $34.31 | $50K |
| 87641 Infectious Agent Detection by DNA/RNA | Office | 1,445 | 768 | $34.31 | $50K |
| 87640 Infectious Agent Detection by DNA/RNA | Office | 1,444 | 769 | $34.31 | $50K |
| 87653 Infectious Agent Detection by DNA/RNA | Office | 1,443 | 768 | $34.31 | $50K |
| 87651 Infectious Agent Detection by DNA/RNA | Office | 1,443 | 768 | $34.31 | $50K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 354 | 43 | $141.82 | $50K |
| 99214 Office E&M - Established | Office | 191 | 163 | $94.44 | $18K |
| 81002 Clinical Chemistry | Office | 187 | 162 | $3.39 | $635 |
| 52000 Cystourethroscopy | Facility | 133 | 102 | $63.39 | $8,431 |
| J1580 Injection, garamycin, gentamicin, up to 80 mg | Facility | 63 | 58 | $1.98 | $125 |
| 96402 Chemotherapy Administration | Office | 59 | 43 | $27.97 | $1,650 |
| 51798 Ultrasound - Nonspecific | Office | 52 | 46 | $8.47 | $441 |
By year: 2022 $1.9M for 42,997 services; 2023 $1.8M for 41,308 services; 2024 $1.9M for 40,222 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87798 Infectious Agent Detection by DNA/RNA | 18,772 | 769 | $34.31 | $644K |
| 87481 Infectious Agent Detection by DNA/RNA | 7,220 | 769 | $34.31 | $248K |
| 87801 Infectious Agent Detection by DNA/RNA | 4,338 | 769 | $68.63 | $298K |
| 87641 Infectious Agent Detection by DNA/RNA | 1,445 | 768 | $34.31 | $50K |
| 87500 Infectious Agent Detection by DNA/RNA | 1,445 | 768 | $34.31 | $50K |
| 87640 Infectious Agent Detection by DNA/RNA | 1,444 | 769 | $34.31 | $50K |
| 87651 Infectious Agent Detection by DNA/RNA | 1,443 | 768 | $34.31 | $50K |
| 87653 Infectious Agent Detection by DNA/RNA | 1,443 | 768 | $34.31 | $50K |
| 81002 Clinical Chemistry | 187 | 162 | $3.39 | $635 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert F Hoofnagle Jr. prescribed most often to Medicare patients was Alfuzosin Hcl Er (Alfuzosin Hcl), with 546 prescriptions and refills. In total Robert F Hoofnagle Jr. wrote 3,114 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alfuzosin Hcl Er Alfuzosin Hcl | 546 | 1,572 | 168 | $18K |
| Tamsulosin Hcl Generic | 338 | 989 | 102 | $9,110 |
| Ciprofloxacin Hcl Generic | 326 | 328 | 222 | $1,715 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 162 | 423 | 59 | $8,968 |
| Xtandi Enzalutamide | 155 | 163 | 20 | $2.3M |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 155 | 157 | 124 | $1,876 |
| Dutasteride Generic | 137 | 383 | 36 | $5,419 |
| Gemtesa Vibegron | 135 | 313 | 42 | $143K |
| Myrbetriq Mirabegron | 113 | 277 | 38 | $122K |
| Orgovyx Relugolix | 92 | 92 | 12 | $243K |
| Fesoterodine Fumarate Er Fesoterodine Fumarate | 71 | 157 | 15 | $7,965 |
| Potassium Citrate Er Potassium Citrate | 70 | 196 | 20 | $9,969 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 68 | 80 | 52 | $242 |
| Metronidazole Generic | 66 | 66 | 49 | $408 |
| Finasteride Generic | 63 | 189 | 19 | $1,112 |
Brand drugs: - claims; generic drugs: 2,493 claims; opioid claims: 52.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert F Hoofnagle Jr. $2,127 ($2,127 in general payments such as food, travel and fees) from 15 companies. The largest payer was Sumitomo Pharma America, Inc. with $428.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 25 | $428 |
| Abbvie Inc. ABBV | 19 | $360 |
| Pfizer Inc. PFE | 12 | $244 |
| Antares Pharma, Inc. | 13 | $182 |
| Endo USA, Inc. | 8 | $171 |
| Janssen Biotech, Inc. JNJ | 6 | $149 |
| Verity Pharmaceuticals Inc. | 4 | $121 |
| Dendreon Pharmaceuticals LLC | 4 | $103 |
| Tolmar, Inc. | 3 | $91.22 |
| Ferring Pharmaceuticals Inc. | 3 | $75.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.